Theriva Biologics
TOVX
TOVX
17 hedge funds and large institutions have $679K invested in Theriva Biologics in 2024 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 1 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$192K | |
| 2 | +$138K | |
| 3 | +$27.9K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$24.6K |
| 5 |
Two Sigma Investments
New York
|
+$18.7K |
Top Sellers
| 1 | -$46K | |
| 2 | -$33.4K | |
| 3 | -$24.5K | |
| 4 |
State Street
Boston,
Massachusetts
|
-$11.5K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$6.26K |